conclusion
Last reviewed 01/2018
This trial does not support the hypothesis that LMWH is superior to aspirin as an acute treatment of stroke in patients with atrial fibrillation.
You are currently on the
global version of this site. To see content specific to your location,
please choose your country or region.
GPnotebook no longer supports Internet Explorer. To ensure the site functions as intended, please
upgrade your browser. Microsoft is encouraging users to upgrade to its more modern
Edge browser for improved security and functionality.